While newly enrolled 340B hospital entrants served higher numbers of Medicaid and rural patients than non-340B hospitals, government-owned 340B hospitals [...] …
Category: Research/Reports
Medicare Part D plans and 340B providers may avoid drugs with negotiated lower Medicare prices to maximize revenue from rebates, [...] …
One-fifth of 340B hospitals will garner no repayment from Medicare for past underpayments, according to a recent analysis by a [...] …
Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...] …
Prescribers who work in federally qualified health centers (FQHCs) believe the 340B program helps their organizations and patients—even if they [...] …
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...] …
Active 340B contract pharmacies reached 17,250 in 2024, according to a conservative think tank using data collected by another group funded by [...] …
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...] …
Significant gaps in hospital and health system’s financial data, including 340B program use, “limit transparency for policymakers, researchers, and consumers,” [...] …
An influential conservative congressional caucus is urging Congress to significantly cut Medicaid spending and “ to ensure that drug discounts [...] …